Actively Recruiting

Phase 4
Age: 35Years +
All Genders
NCT07174349

Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

Led by Mayo Clinic · Updated on 2026-04-03

20

Participants Needed

1

Research Sites

142 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this research is to see if the use of tamsulosin can decrease both the incidence and duration of urinary retention, as well as hospital length of stay following spine surgery.

CONDITIONS

Official Title

Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

Who Can Participate

Age: 35Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Scheduled for cervical laminectomy
  • Scheduled for cervical posterior fusion
  • Scheduled for cervical anterior/posterior fusion
  • Scheduled for lumbar laminectomy
  • Scheduled for lumbar posterolateral fusion
  • Scheduled for lumbar interbody fusion
Not Eligible

You will not qualify if you...

  • Scheduled for cervical anterior discectomy and fusion
  • Scheduled for cervical anterior corpectomy
  • Scheduled for cervical posterior discectomy
  • Scheduled for cervical foraminotomy
  • Scheduled for lumbar discectomy (METRx or open)
  • Scheduled for lumbar foraminotomy
  • Scheduled for lumbar anterior fusion
  • Has myelopathy with bladder dysfunction
  • Currently taking alpha-antagonist drugs such as alfuzosin, doxazosin, prazosin, terazosin, tamsulosin, or phenoxybenzamine
  • History of allergy or sensitivity to tamsulosin or other alpha-antagonists
  • History of prostatectomy or urologic surgery involving bladder or urethra
  • Has severe liver disease or end-stage renal disease
  • Taking strong inhibitors of CYP3A4 like ketoconazole, itraconazole, clarithromycin, ritonavir, indinavir/ritonavir, lopinavir/ritonavir, or conivaptan
  • Has mental disability or is a prisoner
  • Pregnant (for anesthesia purposes)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905

Actively Recruiting

Loading map...

Research Team

N

Neurologic Surgery Research Team

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here